ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

EQ Equillium Inc

1.71
-0.10 (-5.52%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Equillium Inc EQ NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.10 -5.52% 1.71 23:00:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.85 1.69 1.85 1.71 1.81
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/4/202407:00BWEquillium Reports Inducement Grant Under Nasdaq Listing Rule..
01/4/202407:00BWEquillium Announces Positive Topline Data from the Type B..
25/3/202415:01BWEquillium Reports on Fourth Quarter and Full Year 2023..
22/3/202407:00BWEquillium to Present at the H.C. Wainwright Autoimmune &..
08/3/202416:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/3/202415:01EDGAR2Form 8-K - Current report
23/2/202416:12EDGAR2Form 8-K - Current report
23/2/202416:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/2/202405:08EDGAR2Form 8-K - Current report
03/1/202417:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202417:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202417:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202307:05EDGAR2Form 8-K - Current report
21/12/202307:00BWEquillium Announces Update on Multi-Cytokine Inhibitors..
20/11/202310:23PRNCAEQ Bank Card launches in Québec as Carte Banque EQ
13/11/202308:00BWEquillium Presents Positive Data from Phase 1b EQUALISE..
08/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:05EDGAR2Form 8-K - Current report
08/11/202315:01BWEquillium Reports Third Quarter 2023 Financial Results and..
06/11/202307:00BWEquillium Announces Data from Phase 1b EQUALISE Study..
19/10/202307:00BWEquillium Announces Abstracts Accepted for Presentation at..
16/10/202307:05EDGAR2Form 8-K - Current report
16/10/202307:00BWEquillium Announces Preclinical Data from New Orally..
05/10/202316:28EDGAR2Form 8-K - Current report
05/10/202316:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/10/202307:00BWEquillium to Host Analyst & Investor Day
02/10/202307:00BWEquillium to Present at the JonesTrading 2023 Healthcare..
20/9/202307:00BWEquillium to Present at the Cantor Fitzgerald Global..
30/8/202307:00BWEquillium to Attend Wells Fargo Healthcare Conference &..
09/8/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:06EDGAR2Form 8-K - Current report
09/8/202315:01BWEquillium Reports Second Quarter 2023 Financial Results and..
02/8/202315:00BWEquillium Announces $7.5 Million Share Repurchase Program
01/6/202307:00BWEquillium to Present at the Jefferies Global Healthcare & LD..
15/5/202307:00BWEquillium Announces Poster Presentation at the Annual..
11/5/202315:01BWEquillium Reports First Quarter 2023 Financial Results and..

Su Consulta Reciente

Delayed Upgrade Clock